Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Inventory (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Change in Inventory for 9 consecutive years, with -$4.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 165.46% year-over-year to -$4.0 million, compared with a TTM value of -$3.2 million through Dec 2025, down 295.19%, and an annual FY2025 reading of -$3.2 million, down 295.19% over the prior year.
  • Change in Inventory was -$4.0 million for Q4 2025 at Puma Biotechnology, down from $885000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $6.1 million in Q4 2024 and bottomed at -$6.4 million in Q3 2024.
  • Average Change in Inventory over 5 years is $103050.0, with a median of -$111000.0 recorded in 2021.
  • The sharpest move saw Change in Inventory soared 3278.74% in 2021, then crashed 854.64% in 2022.
  • Year by year, Change in Inventory stood at -$97000.0 in 2021, then plummeted by 854.64% to -$926000.0 in 2022, then soared by 251.3% to $1.4 million in 2023, then soared by 331.91% to $6.1 million in 2024, then tumbled by 165.46% to -$4.0 million in 2025.
  • Business Quant data shows Change in Inventory for PBYI at -$4.0 million in Q4 2025, $885000.0 in Q3 2025, and -$160000.0 in Q2 2025.